Future research will delve into the interaction between MST1 and other metabolic pathways, comprehend its role in human models, and assess MST1-targeted interventions in clinical scenarios, facilitating the transition of MST1 from fundamental mechanisms to clinical treatment and offering a novel paradigm for precise intervention of NAFLD [104, 105]. The gene discussed is MST1; the disease is metabolic dysfunction-associated steatotic liver disease.